Results 71 to 80 of about 1,368 (214)
Basic &Clinical Pharmacology &Toxicology, Volume 137, Issue 5, November 2025.ABSTRACT With the increasing prevalence of potentially inappropriate medications in low‐ and middle‐income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking.
Anjan Khadka +4 more
wiley +1 more source
BJGP OpenBackground: Opioid and gabapentinoid prescribing has increased substantially in recent years despite having limited effectiveness in treating chronic primary pain.
Charlotte L Parbery-Clark +2 more
doaj +1 more source
Data in Brief, 2020 The dataset covers the equations and procedure used for the estimation of an older adult's total annual medication costs, across Canadian provinces and territories; detailed to report pharmacy margin, government share, and patient share.
Sarah Abu Fadaleh +4 more
doaj +1 more source
Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review. [PDF]
, 2022 OBJECTIVE To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs).
Aubert, Carole Elodie +2 more
core +1 more source
The Barriers to Deprescription in Older Patients: A Survey of Spanish Clinicians
Healthcare, 2023 Background and objective: There are barriers to deprescription that hinder its implementation in clinical practice. The objective of this study was to analyse the main barriers and limitations of the deprescription process perceived by physicians who care for multipathological patients.
Marta Mejías-Trueba +4 more
openaire +5 more sources
La pharmacogénomique: perspectives et enjeux éthico-juridiques [PDF]
, 2004 La pharmacogénomique est l’étude de la totalité des gènes impliqués dans les réactions aux médicaments. Cette nouvelle technique de développement des médicaments laisse entrevoir d’immenses possibilités, elle soulève également de nombreuses questions ...
Joly, Yann
core
É possivel desprescrever medicamentos agonistas dos receptores benzodiazepínicos em idosos? [PDF]
, 2023 Aim: to analyze the viability and related factors for deprescribing benzodiazepine receptor agonists (BZRA).Methods: this is a longitudinal, prospective, interventional study performed with older adults assisted at a geriatric psychiatry outpatient ...
Cataldo Neto, Alfredo +4 more
core +1 more source
The impact of a multifaceted intervention to reduce potentially inappropriate prescribing among discharged older adults: a before-and-after study [PDF]
, 2020 Background Potentially inappropriate prescribing (PIP) is associated with the incidence of adverse drug reactions, drug-related hospitalization and other negative outcomes in older adults.
Akkawi, Muhammad Eid +2 more
core +1 more source
Health Expectations, Volume 28, Issue 5, October 2025.Visual Abstract ABSTRACT Background Gender inequality in mental health is a persistent challenge that requires innovative solutions for its resolution. Interventions in primary care can be useful in narrowing the gap in the consumption of psychotropic drugs.
Amaia Cuesta‐Zigorraga +1 more
wiley +1 more source
Deprescribing psychotropic drugs in a geriatric psychiatry outpatient clinic
Geriatrics, Gerontology and AgingObjective: To describe the psychotropic drug deprescription process in older patients of a geriatric psychiatry outpatient clinic. Methods: We conducted a quasi-experimental study of people aged < 60 years who were treated at Hospital São Lucas ...
Natascha Melo Linkievicz +4 more
doaj +1 more source